-+ 0.00%
-+ 0.00%
-+ 0.00%

Radiopharm Theranostics Secures FDA IND Approval to Launch Phase I Clinical Trial Targeting B7H3 with Betabart (RV-01)

Reuters·07/28/2025 11:41:46

Please log in to view news